Antimicrobial Drugs Flashcards

1
Q

how were INFECTIONS treated before ANTIMICROBIALS were developed?

A
  • thought of HUMORS (ex. BLOOD, PHLEGM, BLACK/YELLOW BILE) have to be in BALANCE to PRESERVE HEALTH
  • thought INFECTIONS = EXCESS OF BLOOD (use of TECHNIQUE of BLOODLETTING)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what were some other medieval medical practices ?

A
  • use of HERBRAL REMEDIES
    use of DRIED CINCHONA BARK (grounded into POWDER) + MIXED WITH WATER
  • used to treat FEVER; BARK CONTAINED QUININE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how FATAL were diseases before ANTIBIOTICS?

A
  • EXTREMELY FATAL!!
  • Streptococcus pyogenes; the CAUSE OF HALF of POST-BIRTH DEATHS + DEATH FROM BURNS
    -
    PNEUMONIA CASES – fatality rate 30 - 40%
  • **Staphylococcus aureous – fatal in 80% INFECTED WOUNDS + TB `
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe Paul Ehrlich–the Magic Bullet

A
  • developed and SPECULATED there are certain CHEMICALS that can DESTROY THE BACTERIA without harm to host
  • development of the idea CHEMOTHERAPY; therapy for diseases using CHEMICALS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe Alexander Fleming

A
  • the first to discover the FIRST ANTIBIOTIC
  • discovered PENICILLIUM FUNGUS–create of antibiotic PENICILLIN; kills S. aureus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

definition of ANTIBIOTIC

A

substance naturally produced by a MICROORGANISM that INHIBITS or KILLS another microorganism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

definition of SYNTHETIC DRUGS

A
  • other group of antimicrobial
  • 1st; was the SULFA DRUGS–found by german scientists while screening SULFONAMIDE DYES
  • used in WWIi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe ANTIBIOTICS

A
  • very easy to find in the ENVIRONMENT
  • USEFUL;
  • can find the SAME ONES OVER AND OVER
  • TOXICITY for the HOST
  • LOW EFFECTIVENESS in the HOST
  • around half of all ANTIBIOTICS made from Streptomyces spp. (type of FILAMENTOUS BACTERIA found in the SOIL)
  • MOLDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe antibiotics in the MODERN AGE

A
  • heavy use of HIGH-THROUGHPUT SCREENING METHODS
  • allows for greater screening of compounds and look for TREATMENT OPTIONS
  • only a COUPLE OF NEW ANTIBIOTICS FOUND
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the MAIN GOAL of ANTIBIOTICS

A

target the pathogen while MINIMIZING HOST DAMAGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the specific pathways to TARGET THE PATHOGEN (6)

A
  • target CELL WALL
  • target PROTEIN SYNTHESIS/RIBOSOMES
  • target CELL MEMBRANE
  • target METABOLISM
  • target NUCLEIC ACID SYNTHESIS
  • target specific ATTACHMENT and RECOGNITION
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

definition of BACTERICIDAL vs. BACTERIOSTATIC

A

BACTERICIDAL:

  • KILLS PATHOGEN

BACTERIOSTATIC:

  • only STOPS GROWTH of pathogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe MICROBIAL CHARACTERISTICS–who are they more effective against?

A
  • many antibiotics MORE EFFECTIVE towards GRAM POSITIVE BACTERIA–due to LIPOPOLYSACC in GRAM NEGATIVE OUTER MEMBRANE
  • Pseudomonas & Burkholderia are typically RESISTANT (due to PORINS–has selective ability for what goes in and out)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe MYCOBACTERIUM

A
  • resistant to LOTS OF CHEMICALS
  • has WAXY LIPID RICH LAYER in CELL WALL; makes them ACID FAST + greater PROTECTION
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe RANGE OF ORGANISMS

A

BROAD SPECTRUM

  • affects a WIDE RANGE OF ORGANISMS (BOTH GRAM + and -)

NARROW SPECTRUM

  • affects only a FEW/SPECIFIC ORGANISMS targeted (ex. affects only GRAM + or MYCOBACTERIUM)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what happens when the PATHOGEN is EUKARYOTIC?

A
  • has more SPECIFIC TARGETS–shares a lot in COMMON PATHWAYS + ENZYMES with the HOST
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what happens with VIRAL INFECTIONS?

A
  • use of HOST MACHINERY
  • targets the VIRAL INFECTION PROCESS;
    ENTRY, FUSION, ASSEMBLY, REPLICATION, and releases MECHANISMS + PROTEINS that are specific to the VIRUS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

describe how antibiotics INTERFERE with CELL WALL SYNTHESIS

A
  • interfers with SYNTHESIS of the PEPTIDOGLYCAN CELL WALL of bacteria
  • is more of a NARROW SPECTRUM; against GRAM + ORGANISMS
  • have different MODES OF ACTIONS

ex. VANCOMYCIN interferes with peptidoglycan, but not in the same way that PENICILLIN does

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how does PENICILLIN interfere with cell wall synthesis?

A
  • PENICILLIN–belongs to GROUP of 50 related antibiotics (known as Beta-Lactams)
  • works by PREVENTING CROSSLINKING of the PEPTIDOGLYCAN CELL WALL
  • WEAKENS CELL WALL&raquo_space;> leads to CELL LYSIS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

describe characteristics of NATURAL PENICILLIN and SEMI-SYNTHETIC PENICILLIN

A

NATURAL PENICILLIN:

  • have PENICILLIN G (injected) + PENICILLIN V (oral)
  • susceptible to Beta-lactamase (begins to INACTIVATE PENICILLIN)

SEMI-SYNTHETIC PENICILLIN:

  • developed by SCIENTIST to overcome the DISADVANTAGES of NATURAL PENICILLIN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

describe the SUBGROUPS in SEMI-SYNTHETIC PENICILLIN

A
  • METHICILLIN - beta-lactamase RESISTANT PENICILLIN
  • AMPICILLIN/AMOXICILLIN - has a more EXTENDED SPECTRUM
  • effective against BOTH GRAM +/- ORGANISMS
  • AUGMENTIN - has AMOXICILLIN (penicillin) + B-lactamase inhibitor (CLAVULANIC ACID)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

describe Cephalosporins

A
  • NATURALLY OCCURRING – within the FUNGI of the GENUS ACREMONIUM
  • is bactericidal
  • has the SAME MODE OF ACTION as B-lactam antibiotics
  • LESS SUSCEPTIBLE to B-lactamases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

describe Polypeptide antibiotics

A
  • BACITRACIN
  • active against GRAM +
  • INHIBITS CELL WALL SYNTHESIS
  • restricted TOP TOPICAL (can cause KIDNEY DAMAGE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

describe VANCOMYCIN

A
  • treatment for LIFE-THREATENING INFECTIONS by GRAM + BACTERIA that are UNRESPONSIVE to other antibiotics
  • targets CELL WALL SYNTHESIS
  • the LAST LINE OF DEFENSE AGAINST MRSA (INTRAVENOUS)
  • has now widespread use; have now VANCOMYCIN RESISTANT ENTEROCOCCI (VRE)
  • has become an OPPORTUNISTIC PATHOGEN in hospital settings
25
Q

describe PROTEIN SYNTHESIS INHIBITORS

A
  • ribosomes in PROKARYOTES are DIFFERENT from EUKARYOTES (70s vs. 80s)
  • have TWO SUBUNITS; 50s & 30s – INDEPENDENTLY TARGETED
  • mitochondria also have 70s ribosomes
26
Q

what are the PROTEIN SYNTHESIS INHIBITORS for the 50s SUBUNIT?

A
  • CHLORAMPHENICOL
  • CLINDAMYCIN
27
Q

describe CHLORAMPHENICOL

A
  • inhibits the FORMATION OF PEPTIDE BONDS
  • is SYNTHETIC; isolated from Streptomyces
  • BACTERIOSTATIC
  • has a BROAD SPECTRUM
28
Q

describe CLINDAMYCIN

A
  • similar MODE OF ACTION to CHLORAMPHENICOL
  • has BROAD SPECTRUM
  • useful in infections caused by MRSA
  • can RARELY CAUSE LIVER DAMAGE
29
Q

what are the PROTEIN SYNTHESIS INHIBITORS of the 30s SUBUNIT?

A
  • AMINOGLYCOSIDES
  • TETRACYCLINE
30
Q

describe AMINOGLYCOSIDES (3)

A
  • interferes with the 30S SUBUNIT by changing its SHAPE; leads to ERROR in mRNA reading
  • is BROAD SPECTRUM
  • targets AEROBIC GRAM +/- organisms

TYPES:
- STREPTOMYCIN (gives PERMANENT DAMAGE to auditory nerves/kidneys)
- GENTAMYCIN (against PSEUDOMONAS)
- NEOMYCIN TOPICAL

31
Q

describe TETRACYCLINE

A
  • interferes with tRNA ATTACHMENT
  • BROAD SPECTRUM
  • can enter small amounts in MAMMALIAN CELLS–can be used in intercellular bacteria (Rickettsia + Chlamydia)
32
Q

describe MACROLIDES

A
  • group of antibiotics that have a MACROCYCLIC LACTONE RING
  • ERYTHROMYCIN;
  • binds to 50S + BLOCKS mRNA MOVEMENT
  • is BACTERIOSTATIC
  • similar spectrum to PENICILLIN G
33
Q

how have new antibiotics developed? (2)

A
  • developed in RESPONE TO VANOMYCIN RESISTANCE
  • LINEZOLID - mainly used vs. MRSA
  • RETAPAMULIN - TOPICAL USE against GRAM + ORGANISMS
34
Q

describe the MECHANISM OF ACTION; injuring the CELL MEMBRANE

A
  • both EUKARYOTES + PROKARYOTES have similar cell membranes
  • needs FATTY ACIDS
  • can target specific FATTY ACID SYNTHESIS PATHWAYS within PROKARYOTES
  • however BACTERIA CAN SCROUNGE LIPIDS FROM HOST
  • have specific antibiotics that ATTACK PLASMA MEMBRANES of BACTERIA
35
Q

describe DAPTOMYCIN and POLYMIXIN B

A

DAPTOMYCIN

  • is BACTERICIDAL
  • against GRAM + BACTERIA

POLYMIXIN B

  • attacks membranes of GRAM - BACTERIAL CELLS (topical only)
36
Q

describe NUCLEIC ACID SYNTHESIS INHIBITORS

A
  • have GYRASE and TOPOISOMERASE IV (EUKARYOTIC CELLS do NOT HAVE THESE)
  • can INTERFERE WITH ENZYMES –antibiotics can prevent BACTERIAL MULTIPLICATION
37
Q

describe RIFAMPICIN

A
  • inhibits RNA SYNTHESIS in both GRAM +/- BACTERIA
  • binds to BACTERIAL RNA POLYMERASE and INHIBITS TRANSCRIPTION
38
Q

describe HOW ANTIBIOTICS INTERFERE WITH METABOLISM

A
  • DOES NOT ATTACK COMMON PATHWAYS like glycolysis or Krebs
  • attacks PATHWAYS UNIQUE to PROGANISM ex. FOLIC ACID SYNTHESIS
39
Q

describe ANTIFUNGAL DRUGS

A
  • affects the STEROLS IN PLASMA MEMBRANE of FUNGI
  • has the PRINCIPAL TARGET of ERGOSTEREOL; important in FUNGAL CELL MEMBRANES–determines FLUDITY, PERMEABILITY, AND ACITIVITY of its MEM-ASSO. PROTEINS
  • begins to AFFECT FUNGAL CELL WALL
  • affects NUCLEIC ACID SYNTHESIS
40
Q

describe POLYENES (affects STEROLS)

A
  • AMPHOTERICIN B
  • can be TOXIC, only have LIMITED USE
41
Q

describe AZOLES (affects STEROLES) - 2

A
  • the MOST WIDELY USED
  • have IMIDAZOLE (topical use)
  • have KETOCONAZOLE (less toxic - can be taken ORALLY)
42
Q

describe ECHINOCANDINS (fungal cell wall)

A
  • UNIQUE–gives good target
  • inhibits the SYNTHESIS OF GLUCANS for the cell wall
43
Q

describe FLUCYTOSINE (nucleic acid synthesis - fungal)

A
  • seen in FUNGI ONLY
  • converted into 5-FLUOROURACIL = interferes with RNA SYNTHESIS
44
Q

describe ANTIPROTOZOAN DRUGS

A
  • QUININE used to CONTROL PROTOZOAN DISEASE
  • use of CHOLROQUINE - used to TREAT MALARIA (now have a lot of RESISTANT STRAINS
  • use of ARTEMISININ - kills the ASEXUAL STAGES of PLASMODIUM
45
Q

describe ANTIHEMINTHIC + THREE TYPES

A
  • greater increase of TAPEWORM due to consumption of SUSHI

TYPES:
- NICLOSAMIDE (is not absorbed in intest.)
- PRAZIQUANTEL (affects PERMEABILITY OF WORM PLASMA MEMBRANE
- IVERMECTIN (WIDE RANGE OF TARGETS)

46
Q

how do we test SUSCEPTIBILITY

A
  • use of DIFFUSION SUSCEPTIBILITY TEST;
    KIRBY0BAUER TEST– shows ZONES OF INHIBITION
  • yields SUSCEPTIBILITY; look to see who is SUSCEPTIBLE or RESISTANT
47
Q

describe COMPONENTS OF DIFFUSION SUSCEPTIBILITY TEST

A
  • has MINIMUM INHIBITORY CONCENTRATION (MIC)
  • HAS MINIMUM BACTERICIDAL CONCENTRATION (MBC)
  • see and look for SERIAL DILUTIONS OF TREATMENT agent against growth
48
Q

how do we ADMINISTER ANTIBIOTICS

A
  • depends on ROUTES
  • DELIVERY focuses on the PROPER QUANTITIY TREATMENT + CORRECT DESTINATION + FASTEST DELIVERY
  • think of SAFETY
  • think of the LEAST DISRUPTION TO THE HOST
49
Q

what are the DELIVERY METHODS (3)?

A

ORAL + LOCAL

  • SIMPLE BUT SLOW
  • can be SELF-ADMIN
  • have BLOOD EFFICACY (low and variable)

IM

  • NEEDLES
  • BLOOD EFFICACY (intermediate)

IV

  • have HYPODERMIC NEEDLE SYSTEm
  • BLOOD EFFICACY (high + cont.)
50
Q

describe DRUG RESISTANCE

A
  • bacteria are HIGHLY RESOURCEFUL
  • not all bacteria are EQUALLY SENSITIVE–have changes in GENOMIC MUTATIONS + HORIZONTAL TRANSFER (transformation + conjugation + transduction)
  • SURVIVE BETTER = ADVANTAGE (natural selection/evolution)
51
Q

describe the MECHANISMS of DRUG RESISTANCE (5)

A
  • INACTIVATES OR DESTROYS DRUGS
  • PREVENTION OF DRUG ENTRY
  • METABOLIC ADAPTATION
  • RESISTANCE PUMPS
  • TARGET MODIFICATION
52
Q

describe how organism INACTIVATES/DESTROYS DRUG

A
  • have creation of MUTANT B-LACTAMASES
  • start to DIGEST METHICILLLIN
  • MRSA resistant
  • more resistance to VANOMYCIN
53
Q

describe how organism PREVENTS DRUG ENTRY

A
  • modification of MEMBRANE PROTEINS
  • has RESISTANCE PUMPS–has a RAPID EFFLUX OF DRUGS
54
Q

describe how organism has METABOLIC ADAPTION

A
  • increase concentration of TARGET PROTEIN TO OVERCOME DRUG EFFECT
55
Q

describe TARGET MODIFICATION

A
  • changes its TARGET to be NO LONGER SUSCEPTIBLE
56
Q

why do we have drug resistance; MISUSE

A
  • have an OVERUSE OF ANTIBITOICS
  • a lot of diseases are VIRAl; continue to PRESCRIBE ANTIBIOTICS
  • feeding animals ANTIBIOTICS FOR GROWTH
57
Q

why do we have drug resistance; THIRD-WORLD NATIONS

A
  • have vary low rates of PRESCRIBED ANTIBIOTICS
  • leads to OVERUSE and IMPROPER USE
58
Q

how to AVOID MAKING MORE DRUG RESISTANCE

A
  • greater maintenance of HIGH CONCENTRATION
  • have PROPER TIME FRAME
  • LIMITATION OF DISTRIBUTION
  • use of MULTIPLE ANTIMICROBIAL to inhibit growth without exception
59
Q

describe MULTIPLE DRUG RESISTANCE

A
  • where DRUG IS RESISTANT TO MORE THAN ONE DRUG
  • typically acquired by PLASMIDS
  • often created in HOSPITALS
  • due to HIGH ANTIMICROBIAL TREATMENT LEVELS
  • ELIMINATION OF SENSITIVE CELLS + selective GROWTH OF RESISTANT CELLS